对动脉样硬化进行组合疗法和药物联合递送系统
Yingxuan Dai1, Li Yang1, Guosheng Cao2
1School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, PR China.
组合疗法和先进的药物联合递送系统为治疗动脉样硬化,一种复杂的炎症性动脉疾病提供了有希望的解决方案. 这些方法旨在改善治疗结果并减少疾病负担.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 动脉样硬化是一种慢性炎症性动脉疾病,具有复杂的病理学,使单一疗法不足.
- 尽管取得了进展,但目前的动脉样硬化治疗由于相互关联的病理因素而面临挑战.
- 现有的治疗策略往往对有效管理动脉样硬化产生不充分的结果.
研究的目的:
- 探索用于治疗动脉样硬化的组合疗法的潜力.
- 审查先进的药物联合递送系统,特别是基于纳米粒子的方法,用于动脉样硬化.
- 突出优化药物管理和提高治疗疗效的创新策略.
主要方法:
- 对动脉样硬化病理特征和风险因素的全面审查.
- 研究用于量化组合治疗疗效的数学模型.
- 现有药物组合的系统总结和纳米粒子药物联合递送系统的最新进展.
主要成果:
- 药物组合疗法对于解决动脉样硬化的多面性质至关重要.
- 基于纳米颗粒的药物联合递送系统显示了增强生物相容性和疗效的潜力.
- 数学模型可以量化联合疗法在治疗动脉样硬化的疗效.
结论:
- 组合疗法和先进的联合输送系统代表了动脉样硬化治疗的前沿.
- 通过创新技术优化药物联合管理可以改善患者的治疗结果.
- 这些策略旨在减少与动脉样硬化相关的显著发病率和死亡率.
更多相关视频
07:20Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
Published on: February 10, 2023
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
相关概念视频
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cardiovascular Drugs: Classification based on Therapeutic Indications
